Mechanism
Interferon-alpha2 (IFN-alpha2) expression in myeloid cells
Assets acting on this target.
- Class
- Lentiviral vector-based gene therapy (hematopoietic stem/progenitor cell therapy)
- Notes
- verified in session 2026-08-25 (owner-delegated review); source: https://clinicaltrials.gov/api/v2/studies/NCT03866109